Table 1 Cost-effectiveness ratios for intermediate degrees of vaccine efficacy in preventing cases of NBPD in Scotland
From: Policymaking based on CERs: changes in costs are not the same as changes in benefits
Assumed preventive power for NBPD | Costs in € Million* | QALY's* | CER | Reduction in CER as percentage |
|---|---|---|---|---|
0% effectiveness for NBPD | 147.7 | 9923 | 14892 | |
Step 1 (10% increase) | 135.6 | 19777 | 6858 | 53.9 |
Step 2 | 123.4 | 29630 | 4167 | 18.1 |
Step 3 | 111.3 | 39483 | 2820 | 9.1 |
Step 4 | 99.1 | 49337 | 2010 | 5.4 |
Step 5 | 87.0 | 59190 | 1470 | 3.6 |
Step 6 | 74.9 | 69044 | 1084 | 2.3 |
Step 7 | 62.7 | 78897 | 795 | 1.9 |
Step 8 | 50.6 | 88750 | 570 | 1.5 |
Step 9 | 38.4 | 98604 | 390 | 1.2 |
Same effectiveness against NBPD as against BPD | 26.3 | 108457 | 242 | 1.0 |